The 2025-2030 World Outlook for Aesthetic Botulinum Toxin-a Drugs - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Aesthetic Botulinum Toxin-a Drugs

Subjects

Out of stock

Price data checked 2 days ago

View at Amazon

One email. No newsletter. No nudges.

Gone for 207 days. Could come back at any time — we're watching for you.

Out of stock 207 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 514 days · 514 data points

Historical

Generating forecast…

Price Distribution

Price distribution over 514 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (514 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 514 days

Description

This study covers the world outlook for aesthetic botulinum toxin-a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of aesthetic botulinum toxin-a drugs as including all commonly understood products falling within this broad category, such as neurotoxic proteins used for medical, cosmetic, and research purposes, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Allergan and Medicis. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZLX7T78
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 05 May 2024

The 2025-2030 World Outlook for Aesthetic Botulinum Toxin-a Drugs

Gone for 207 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2021-2026 World Outlook for Botulinum Toxins

The 2026-2031 World Outlook for Botulinum Toxins

The 2025-2030 World Outlook for Botulinum Toxin and HA Dermal Fillers

The 2023-2028 Outlook for Botulinum Toxins in the United States

The 2023-2028 Outlook for Botulinum Toxins in China

The 2023-2028 World Outlook for Botulinum Toxin and HA Dermal Fillers

The 2026-2031 World Outlook for Botulinum Toxin and HA Dermal Fillers

The 2021-2026 World Outlook for Facial Injectables

Botox & Beyond

Optimizing Aesthetic Toxin Results (Series in Cosmetic and Laser Therapy)

The 2026-2031 World Outlook for Facial Aesthetics

The 2023-2028 World Outlook for Cosmetic Surgery, Facial Aesthetics, and Medical Lasers

The 2025-2030 World Outlook for Anti-Aging and Skin Rejuvenation Energy-Based Aesthetic Devices

The 2023-2028 World Outlook for Anti-Aging Cosmetic Skin Care

Botulinum Toxins in Clinical Aesthetic Practice 3E, Volume Two: Functional Anatomy and Injection Techniques: 2 (Series in Cosmetic and Laser Therapy)

The 2023-2028 Outlook for Facial and Body Toning Systems in China

The 2026-2031 World Outlook for Anti Wrinkles Products

The 2025-2030 World Outlook for Plastic Surgery Instruments

The 2023-2028 Outlook for Facial and Body Toning Systems in India

The 2023-2028 Outlook for Facial Treatments in the United States

The 2026-2031 World Outlook for Anti-Aging, Anti-Wrinkle Products

The 2016-2021 Outlook for Facial and Body Toning Systems in the United States

Botulinum Toxins in Clinical Aesthetic Practice 3E: Two Volume Set (Series in Cosmetic and Laser Therapy)

The 2025-2030 World Outlook for Non-Invasive Body Contouring Devices